Amini A et al (2014) Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review. Radiat Oncol 9:210

Article  PubMed  PubMed Central  Google Scholar 

Palma DA et al (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 393(10185):2051–2058

Article  PubMed  Google Scholar 

Postmus PE et al (2017) Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 28(4):iv1–iv21

Article  CAS  PubMed  Google Scholar 

Chargari C et al (2016) Optimize and refine therapeutic index in radiation therapy: overview of a century. Cancer Treat Rev 45:58–67

Article  PubMed  Google Scholar 

Timmerman R et al (2003) Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124(5):1946–1955

Article  PubMed  Google Scholar 

Wulf J et al (2005) Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 77(1):83–87

Article  PubMed  Google Scholar 

Onishi H et al (2007) Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2(7 Suppl 3):S94–S100

Article  PubMed  Google Scholar 

Haseltine JM et al (2016) Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree. Pract Radiat Oncol 6(2):e27–e33

Article  PubMed  Google Scholar 

Landry G, Corradini S, Belka C (2020) Magnetic resonance-guided radiation therapy: the beginning of a new era. Radiat Oncol 15(1):163

Article  PubMed  PubMed Central  Google Scholar 

Corradini S et al (2019) MR-guidance in clinical reality: current treatment challenges and future perspectives. Radiat Oncol 14(1):92

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cusumano D et al (2018) Predicting tumour motion during the whole radiotherapy treatment: a systematic approach for thoracic and abdominal lesions based on real time MR. Radiother Oncol 129(3):456–462

Article  PubMed  Google Scholar 

Chin S et al (2020) Magnetic resonance-guided radiation therapy: a review. J Med Imaging Radiat Oncol 64(1):163–177

Article  PubMed  Google Scholar 

Noel CE et al (2015) Comparison of onboard low-field magnetic resonance imaging versus onboard computed tomography for anatomy visualization in radiotherapy. Acta Oncol 54(9):1474–1482

Article  PubMed  Google Scholar 

Benedict SH et al (2010) Stereotactic body radiation therapy: the report of AAPM task group 101. Med Phys 37(8):4078–4101

Article  PubMed  Google Scholar 

Diez P et al (2022) UK 2022 consensus on normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy. Clin Oncol 34(5):288–300

Article  CAS  Google Scholar 

Bezjak A et al (2019) Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG oncology/RTOG 0813 trial. J Clin Oncol 37(15):1316–1325

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gungor G et al (2021) Time analysis of online adaptive magnetic resonance-guided radiation therapy workflow according to anatomical sites. Pract Radiat Oncol 11(1):e11–e21

Article  PubMed  Google Scholar 

Finazzi T et al (2020) Stereotactic MR-guided adaptive radiation therapy for peripheral lung tumors. Radiother Oncol 144:46–52

Article  PubMed  Google Scholar 

Dunlap NE et al (2010) Chest wall volume receiving 〉 30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76(3):796–801

Article  PubMed  Google Scholar 

Finazzi T et al (2020) Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for high-risk lung tumors. Int J Radiat Oncol Biol Phys 107(2):270–278

Article  PubMed  Google Scholar 

Finazzi T et al (2019) Role of on-table plan adaptation in MR-guided ablative radiation therapy for central lung tumors. Int J Radiat Oncol Biol Phys 104(4):933–941

Article  PubMed  Google Scholar 

Henke LE et al (2019) Stereotactic MR-guided online adaptive radiation therapy (SMART) for ultracentral thorax malignancies: results of a phase 1 trial. Adv Radiat Oncol 4(1):201–209

Article  PubMed  Google Scholar 

Lindberg K et al (2021) The HILUS-trial—a prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy. J Thorac Oncol 16(7):1200–1210

Article  PubMed  Google Scholar 

Levy A et al (2024) Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC: EORTC 22113–08113 lungtech phase II trial results. J Thorac Oncol

Giuliani ME et al (2024) Stereotactic radiation for ultra-central non-small cell lung cancer: a safety and efficacy trial (SUNSET). Int J Radiat Oncol Biol Phys 120(3):669–677

Article  PubMed  Google Scholar 

Henke L et al (2018) Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen. Radiother Oncol 126(3):519–526

Article  PubMed  Google Scholar 

Regnery S et al (2021) Adaptive MR-guided stereotactic radiotherapy is beneficial for ablative treatment of lung tumors in high-risk locations. Front Oncol 11:757031

Article  PubMed  Google Scholar 

Hering S et al (2024) The role of online MR-guided multi-fraction stereotactic ablative radiotherapy in lung tumours. Clin Transl Radiat Oncol 45:100736

PubMed  PubMed Central  Google Scholar 

Merckel LG et al (2024) Stereotactic body radiotherapy of central lung tumours using a 1.5 T MR-linac: first clinical experiences. Clin Transl Radiat Oncol 45:100744

CAS  PubMed  PubMed Central  Google Scholar 

Finazzi T et al (2020) Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy. Phys Imaging Radiat Oncol 14:17–23

Article  PubMed  PubMed Central  Google Scholar 

Padgett KR et al (2018) Feasibility of adaptive MR-guided Stereotactic body radiotherapy (SBRT) of lung tumors. Cureus 10(4):e2423

PubMed  PubMed Central  Google Scholar 

Siva S, Ball DL (2019) Single fraction SBRT for early stage lung cancer-less is more? Int J Radiat Oncol Biol Phys 103(5):1085–1087

Article  PubMed  Google Scholar 

Eufemon Cereno R et al (2023) Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial. Radiother Oncol 182:109576

Article  PubMed  Google Scholar 

Van Oirschot M et al (2022) Determining planning priorities for SABR for oligometastatic disease: a secondary analysis of the SABR-COMET phase II randomized trial. Int J Radiat Oncol Biol Phys 114(5):1016–1021

Article  PubMed  Google Scholar 

Sahin B et al (2019) First 500 fractions delivered with a magnetic resonance-guided radiotherapy system: initial experience. Cureus 11(12):e6457

PubMed  PubMed Central  Google Scholar 

Sayan M et al (2020) Patient-reported tolerance of magnetic resonance-guided radiation therapy. Front Oncol 10:1782

Article  PubMed  PubMed Central